DE AMICI, MARA
 Distribuzione geografica
Continente #
NA - Nord America 1.767
EU - Europa 1.217
AS - Asia 928
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.916
Nazione #
US - Stati Uniti d'America 1.758
CN - Cina 898
IE - Irlanda 466
UA - Ucraina 222
FI - Finlandia 163
DE - Germania 136
SE - Svezia 74
IT - Italia 64
GB - Regno Unito 45
BE - Belgio 14
VN - Vietnam 14
ES - Italia 13
CA - Canada 9
FR - Francia 9
IN - India 7
IR - Iran 3
KR - Corea 2
MU - Mauritius 2
NL - Olanda 2
RO - Romania 2
RU - Federazione Russa 2
TR - Turchia 2
AU - Australia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EU - Europa 1
GR - Grecia 1
JP - Giappone 1
LV - Lettonia 1
PT - Portogallo 1
SG - Singapore 1
Totale 3.916
Città #
Dublin 465
Chandler 377
Jacksonville 322
Nanjing 257
Ashburn 125
Nanchang 125
Princeton 90
Lawrence 89
Medford 87
Beijing 78
Hebei 77
Wilmington 73
Changsha 69
Shenyang 68
Helsinki 62
Jiaxing 61
Ann Arbor 54
Hangzhou 53
Tianjin 37
Boardman 31
Shanghai 27
Seattle 22
New York 18
Woodbridge 17
Brussels 14
Dong Ket 14
Milan 14
Los Montesinos 13
Norwalk 13
Pavia 13
Verona 11
Fairfield 10
Toronto 9
Washington 9
Kunming 8
Zhengzhou 7
Cambridge 6
Dearborn 6
Orange 6
Des Moines 5
Houston 5
Jinan 5
Redwood City 5
Guangzhou 4
Los Angeles 4
Tappahannock 4
Barlassina 3
Duncan 3
Mulazzano 3
Ningbo 3
Sacramento 3
Ardabil 2
Auburn Hills 2
Bangalore 2
Bari 2
Borås 2
Changchun 2
Falkenstein 2
Frankfurt am Main 2
Fuzhou 2
Legnano 2
Nuremberg 2
Pune 2
San Francisco 2
Siena 2
Taizhou 2
Tomsk 2
Waltham 2
Alexandria 1
Athens 1
Brno 1
Chicago 1
Geislingen an der Steige 1
Gunzenhausen 1
Lanzhou 1
Las Vegas 1
Mainz 1
Menlo Park 1
Padova 1
Philadelphia 1
Redmond 1
Reghin 1
Shijiazhuang 1
Singapore 1
Stanton 1
Sydney 1
Walnut 1
Wayne 1
Wuhan 1
Totale 2.939
Nome #
Effects of 3'-hydroxyfarrerol (IdB 1031), a novel flavonoid agent, on phagocyte products 87
Serum neopterin levels in spontaneous urticaria and atopic dermatitis. 75
Cross reactivity between recombinant parvalbumin of carp and cod and recombinant grass molecules 75
Interacting Agents for the Risk Assessment of Allergies in Newborn Babies 74
Tetanus toxoid IgE may be useful in predicting allergy during childhood. 67
Activation of PPARgamma enhances in vitro the immunosuppressive effect of cyclosporine on T lymphocytes. 66
Serum IL-4 as a marker of immunological response to sublingual immunotherapy. 65
Bevacizumab treatment followed by maintenance in life-threatening POEMS syndrome. 63
Interacting Agents through a Web-based Health Serviceflow Management System 63
Serum eosinophilic cationic protein: is there a role in respiratory disorders? 62
Comparison of serum specific IgE and skin prick test in polysensitized children. 62
Sublingual immunotherapy affects specific antibody and TGF-beta serum levels in patients with allergic rhinitis. 60
Pidotimod may prevent recurrent respiratory infections in children. 59
Serum IL-9 levels and sublingual immunotherapy: preliminary report. 58
Serum IL-17 levels in patients with allergic rhinitis. 58
Adiponectin, IL-10 and metabolic syndrome in obese children and adolescents. 58
The Circulating Level of Soluble Receptor for Advanced Glycation End Products Displays Different Patterns in Ulcerative Colitis and Crohn’s Disease: A Cross-Sectional Study 58
Serum adiponectin levels in patients with pollen-induced allergic rhinitis. 57
Pentraxin 3 In Children Suffering From Allergic Rhinitis 56
Changes in circulating pro-angiogenic cytokines, other than VEGF, before progression to sunitinib therapy in advanced renal cell carcinoma patients. 55
Adenoids and clinical symptoms: Epidemiology of a cohort of 795 pediatric patients 55
Allergen-specific immunoglobulin E and allergic rhinitis severity 54
Adipokines and sublingual immunotherapy: preliminary report. 53
The Mucosal Innate Immune Response in Primary Human Papillomavirus Infection: A Pilot Study 53
Anti-Zinc Transporter Protein 8 Antibody Testing Is Not Informative in Routine Prediabetes Screening in Young Patients with Autoimmune Thyroiditis and Celiac Disease 53
Comparison of serum specific IgE and skin prick test in polysensitized patients. 53
Increased serum inflammatory markers as predictors of airway obstruction. 52
Reference values of IgG and IgG4 serum levels specific for inhalant allergens in non-atopic children 52
Phleum pratense molecular pattern across Italy 50
−295 T-to-C promoter region IL-16 gene polymorphism is associated with Whipple’s disease 50
Allostatic load in neurologically impaired (ni) children: the importance of the nutritional status. 50
Predictive value of baseline serum vascular endothelial growth factor and neutrophil gelatinase-associated lipocalin in advanced kidney cancer patients receiving sunitinib 50
Eosinophils and C4 predict clinical failure of combination imunotherapy with very low dose subcutaneous interleukin-2 and interferon in renal cell carcinoma patients 49
Alterations of Inflammatory and Matrix Production Indices in Celiac Disease With Low Bone Mass on Long-term Gluten-free Diet. 49
Serum interleukin-17 levels are related to clinical severity in allergic rhinitis. 48
Serum Leptin Levels Depend on Allergen Exposure in Patients with Seasonal Allergic Rhinitis 48
TGF-beta and IL-17 serum levels and specific immunotherapy. 48
Immunoglobulin E levels in the 1st year of life. 48
CD64 expression on monocytes in children with adenoid hypertrophy. 48
Hunger hormone profile monitoring after gastroplication in an adolescent 48
Serotonin in Allergic Rhinitis: a Possible Role for Behavioural Symptoms 48
Serum IL-17 after one course of sublingual immunotherapy in allergic rhinitis to birch 47
Adenoid hypetrophy: definition of some risk factors 47
Clinical use of basophil activation test in drug, food and hymenoptera venom allergies 47
Optimizing allergic disease prevention screening in newborns. 46
Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: The hidden role of thyroid autoimmunity 46
Allergen-specific Ig classes in non-allergic individuals. 46
Serum adiponectin levels in patients with seasonal allergic rhinitis 45
Two year sublingual immunotherapy affects serum leptin. 43
Serum IgE for Bet v 1 in patients affected by atopic dermatitis 43
Prediction of allergy by total serum IgE measurements in infancy: a 10-year-follow-up 43
Serum Interleukin-9 Levels Are Associated With Clinical Severity in Children With Atopic Dermatitis. 42
Reference values for IgG and IgG4 serum levels specific for inhalant allergens in non-atopic subjects. 41
Pentraxin 3 Serum Levels In Children With Atopic Dermatitis 40
Omalizumab in children with severe allergic asthma: The Italian real- life experience 40
Epicardial Fat Thickness in Non-Obese Neurologically Impaired Children: Association with Unfavorable Cardiometabolic Risk Profile 40
Sublingual immunotherapy may affect serum neopterin: preliminary findings. 39
ELISPOT and ELISA assessment of interferon-gamma after sublingual immunotherapy 39
Cord and blood levels of newborn IgE: Correlation, role and influence of maternal IgE 39
Serum Calprotectin Level in Children: Marker of Obesity and its Metabolic Complications. 38
Pentraxin 3 and D-dimer in children with asthma: A real-world study 38
Serum vascular endothelial growth factor in allergic rhinitis and systemic lupus erythematosus. 37
Nutritional status and metabolic profile in neurologically impaired pediatric surgical patients 36
Long-term outcome after robotic-assisted gastroplication in adolescents: Hunger hormone and food preference changes two case reports 36
Maternal and fetal Leptin and interleukin 33 concentrations in pregnancy complicated by obesity and preeclampsia 36
Basophil activation test in children with autoimmune chronic spontaneous urticaria: Is it ready for clinical practice? 36
Serum transforming growth factor-beta levels depend on allergen exposure in allergic rhinitis. 35
Serum resistin in persistent allergic rhinitis: preliminary data in adults. 34
Serum adipsin levels in patients with seasonal allergic rhinitis: preliminary data. 33
Profiles of birch sensitization (Bet v 1, Bet v 2, and Bet v 4) and oral allergy syndrome across Italy 33
Immunoglobulin production pattern in allergic and non-allergic subjects 32
Serum leptin levels in patients with pollen-induced allergic rhinitis. 32
Hyper IgE syndrome: anaphylaxis in a patient carrying the N567D STAT3 mutation 30
Molecular evolution in food allergy diagnosis 29
null 28
Innate and adaptive immunity in self-reported nonceliac gluten sensitivity versus celiac disease 28
Spontaneous (Autoimmune?) Chronic Urticaria in children: current evidences, diagnostic pitfalls and therapeutical management 28
Tetanus Toxoid IgE May Be Useful In Predicting Allergy During Childhood 27
WALNUT SENSITIZATION IN PEDIATRIC AGE: A PRELIMINARY STUDY 27
null 26
PREDICTION OF ALLERGY BY TOTAL SERUM IgE MEASUREMENTS IN INFANCY: A10-YEAR FOLLOW-UP 25
Soluble HLA-G concentrations in maternal blood and cervical vaginal fluid of pregnant women with preterm premature rupture of membranes 25
Tryptase and histamine may support oral food challenge in the diagnosis of allergy 24
Long-term outcome after robotic-assisted gastroplication in adolescents: Hunger hormone and food preference changes two case reports 24
Subtraction Ictal SPECT coregistered to MRI (SISCOM) as a guide in localizing childhood epilepsy 23
Simultaneous detection of circulating immunological parameters and tumor biomarkers in early stage breast cancer patients during adjuvant chemotherapy 21
EPICARDIAL FAT THICKNESS IN NON-OBESE NEUROLOGICALLY IMPAIRED CHILDREN: ASSOCIATION WITH UNFAVORABLE CARDIOMETABOLIC RISK PROFILE 20
Soluble HLA-G concentrations in obese women during pregnancy and in cord blood 19
Increased serum inflammatory markers as predictors of airway obstruction 17
SERUM IMMUNOGLOBULIN IgE IN A PEDIATRIC POPULATION: A RETROSPECTIVE ANALYSIS 16
Letters to the Editor 11
Totale 4.014
Categoria #
all - tutte 15.343
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.343


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20197 0 0 0 0 0 0 0 0 0 0 2 5
2019/20201.045 309 451 0 42 3 47 2 53 10 85 43 0
2020/2021477 55 44 11 46 2 58 6 83 16 71 59 26
2021/2022365 2 2 13 6 4 5 8 27 22 6 54 216
2022/20231.204 136 74 18 76 107 112 8 76 537 10 29 21
2023/2024435 72 78 19 37 48 106 10 40 3 13 9 0
Totale 4.014